Tscan Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8k | 301 | 5.83 |
| 2023-09-30 | $731 | 286 | 2.56 |
| 2023-06-30 | $200 | 80 | 2.50 |
| 2022-12-31 | $112 | 73 | 1.55 |
| 2022-09-30 | $0 | 72 | 0.00 |
| 2022-06-30 | $0 | 46 | 0.00 |
| 2022-03-31 | $0 | 41 | 0.00 |
| 2021-12-31 | $0 | 41 | 0.00 |
| 2021-09-30 | $0 | 41 | 0.00 |